Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (771-780 of 850) with videos related to

Pageof 85
Sort By:
European Urology Oncology|March 3, 2023
Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate CancerAli Sabbagh, Samuel L Washington, Derya Tilki, et al.
Annals of Surgical Oncology|May 27, 2025
Cancer-Specific Mortality of Partial Cystectomy Versus Radical Cystectomy in T2N0M0 Urothelial Bladder CancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
Annals of Surgical Oncology|May 2, 2025
Comparison of In-Hospital Outcomes at Robot-Assisted Versus Open Partial NephrectomyFrancesco Di Bello, Natali Rodriguez Penaranda, Andrea Marmiroli, et al.
Japanese Journal of Clinical Oncology|February 18, 2024
A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancerReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
European Urology Oncology|May 10, 2024
Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen-targeted Salvage SurgerySophie Knipper, Flemming Lischewski, Daniel Koehler, et al.
The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Unilateral prostate cancer cannot be accurately predicted in low-risk patientsHendrik Isbarn, Pierre I Karakiewicz, Susanne Vogel, et al.
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Oncotarget|January 10, 2018
Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancerMartina Kluth, Simon Jung, Omar Habib, et al.
World Journal of Urology|October 4, 2025
Effect of neoadjuvant chemotherapy on years of life lost in radical cystectomy-treated T2N0M0 bladder cancer patientsMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
Pageof 85

Showing results (771-780 of 850) with videos related to

Sort By:
Pageof 85
European Urology Oncology|March 3, 2023
Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate CancerAli Sabbagh, Samuel L Washington, Derya Tilki, et al.
Annals of Surgical Oncology|May 27, 2025
Cancer-Specific Mortality of Partial Cystectomy Versus Radical Cystectomy in T2N0M0 Urothelial Bladder CancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
Annals of Surgical Oncology|May 2, 2025
Comparison of In-Hospital Outcomes at Robot-Assisted Versus Open Partial NephrectomyFrancesco Di Bello, Natali Rodriguez Penaranda, Andrea Marmiroli, et al.
Japanese Journal of Clinical Oncology|February 18, 2024
A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancerReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
European Urology Oncology|May 10, 2024
Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen-targeted Salvage SurgerySophie Knipper, Flemming Lischewski, Daniel Koehler, et al.
The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Unilateral prostate cancer cannot be accurately predicted in low-risk patientsHendrik Isbarn, Pierre I Karakiewicz, Susanne Vogel, et al.
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Oncotarget|January 10, 2018
Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancerMartina Kluth, Simon Jung, Omar Habib, et al.
World Journal of Urology|October 4, 2025
Effect of neoadjuvant chemotherapy on years of life lost in radical cystectomy-treated T2N0M0 bladder cancer patientsMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
Pageof 85